Dr James Curran, mostly known for his work at the Centers for Disease Control and Prevention (CDC) in the 1980's, pinpoints several key events and persons linked with the very first years of discoveries on HIV and AIDS.

XIX International AIDS Conference. Interview with Adeeba Kamarulzaman from the University of Malaya in Kuala Lumpur, Malaysia. She talks about the obstacles and possibilities of ending HIV and AIDS.

XIX International AIDS Conference. The co-chair of this conference, Diane Havlir, has been working with HIV/AIDS since the early 80's at San Francisco General Hospital. Here she talks about the time of the outbreak and about the tools needed to end HIV and AIDS.

XIX International AIDS Conference. Interview with Gregg Alton from the Gilead Sciences, Inc. a pharmaceutical company working with health care services, policy makers, etc. to develop effective treatment, treatment as prevention and promoting access to care.

XIX International AIDS Conference. Matias Ostrowski from University of Buenos Aires is part of the CNIHR program lead by IAS and NIH. He is involved in basic research on the cell biology of HIV with the target of creating new ideas for drug development.

XIX International AIDS Conference. Interview with the Immunologist Michael Elliot from University of Rochester on the CNIHR program which involves scientist not previously engaged in the HIV research field to develop new thinking withing the field.

XIX International AIDS Conference. Session on Pediatrics with medical doctors and scientists discussing prevention of mother-to-child transmission and the development of antiretroviral treatments suitable for infants and small children.

XIX International AIDS Conference. Session "Gender and Science: Shifting the Paradigm in HIV Research" discussing the inclusion of structural and biological gender factors as part of HIV research, and the participation of women living with HIV in clinical trials.

XIX International AIDS Conference in Washington D.C. Dr. Gottfried Hirnschall, Director of the Department of HIV and Global Hepatitis Programme of WHO, speaks at the plenary session Expanding HIV Testing and Treatment Globally.

XIX International AIDS Conference. Interview with Bernhard Schwartzlander from UNAIDS in Geneva. Schwartzländer is an expert on the statistics of HIV/AIDS. He talks about the HIV prevalence globally and the importance of early diagnosis and ARV treatment.

XIX International AIDS Conference. Sharon Lewin from Monash University in Melbourne discusses the possibilities of ending AIDS and scientific breakthroughs during the 30 years of the epidemic, for instance the discovery that some people are resistant to HIV.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.